Adding Ibrance to maintenance therapy extends progression-free survival by 15.2 months in HR-positive, HER2-positive ...
Fylrevy has been shown to lead to a statistically significant reduction in the frequency and severity of moderate-to-severe menopausal vasomotor symptoms.
Isla Sneddon died at age 17, after being given a fatal cancer diagnosis six months earlier. She had chest pain and a lump ...
When the Food and Drug Administration announced that the agency would be removing the black-box warning from hormone ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results